Discovery of a new class based on 6-methoxypyrimidine as efficient low weight reversible inhibitors of SARS-CoV-2 main protease (M) with antiviral activity.

Publication date: Sep 03, 2026

The main protease M of SARS-CoV-2 is an important enzyme for the viral cycle and its inhibition affects replication and infection propagation. In this way, it has been reported as an excellent target for drug design. In this work, we discovered a low molecular weight non-peptide, heterocyclic inhibitor, that inactivates M. Initially, we screened a focused chemical library of heterocyclic compounds against M that included several cysteine protease inhibitors. A compound based on a 6-methoxypyrimidine scaffold was identified as an inhibitor of this enzyme and structure-activity relationship studies revealed all the important groups for M inhibition. Optimization of the hit compound provided a small (306 g/mol) competitive inhibitor that inactivated M activity, being non-promiscuous to other cysteine proteases such as PL, human CatL, and cruzain. PH521 (4f) presented increased potency against SARS-CoV-2 infection of cells being 20-fold more potent than the initial hit compound.

Open Access PDF

Concepts Keywords
306g 6-Methoxypyrimidine derivatives
Competitive Antiviral activity
Inactivated Hit optimization
Library Reversible inhibitors
Methoxypyrimidine RT-qPCR
SARS-CoV-2 M(pro)

Semantics

Type Source Name
disease MESH infection
disease MESH included
drug DRUGBANK L-Cysteine
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH cgh
drug DRUGBANK Ribostamycin
disease MESH severe acute respiratory syndrome
disease MESH breakthrough infections
drug DRUGBANK Coenzyme M
drug DRUGBANK Serine
pathway KEGG Endocytosis
pathway REACTOME Translation
drug DRUGBANK Papain
disease MESH weight gain
drug DRUGBANK Hyaluronic acid
pathway KEGG Viral replication
drug DRUGBANK Gold
drug DRUGBANK Aniline
drug DRUGBANK Benzylamine
drug DRUGBANK Oxyquinoline
drug DRUGBANK L-Leucine
disease MESH ACC
disease MESH HTX
drug DRUGBANK Dimethyl sulfoxide

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *